A Peptide Inhibitor of FOXP3 Impairs Regulatory T Cell Activity and Improves Vaccine Efficacy in Mice-Reference-Cited by-同舟云学术

A Peptide Inhibitor of FOXP3 Impairs Regulatory T Cell Activity and Improves Vaccine Efficacy in Mice

Published:2010-09-24 Issue:9 Volume:185 Page:5150-5159
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Casares Noelia,Rudilla Francesc,Arribillaga Laura,Llopiz Diana,Riezu-Boj José Ignacio,Lozano Teresa,López-Sagaseta Jacinto,Guembe Laura,Sarobe Pablo,Prieto Jesús,Borrás-Cuesta Francisco,Lasarte Juan José

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference52 articles.

1. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression

2. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3

3. Certified Professionals

4. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

5. JM2, encoding a fork head–related protein, is mutated in X-linked autoimmunity–allergic disregulation syndrome

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a proteolysis targeting chimera (PROTAC) as a potent regulator of FOXP3;Bioorganic & Medicinal Chemistry Letters;2024-11

2. Foxp3 inhibitory peptide encapsulated in a novel CD25-targeted nanoliposome promotes efficient tumor regression in mice;Acta Pharmacologica Sinica;2024-07-29

3. Tethered IL15-IL15Rα augments antitumor activity of CD19 CAR-T cells but displays long-term toxicity in an immunocompetent lymphoma mouse model;Journal for ImmunoTherapy of Cancer;2024-07

4. Emerging roles of FOXK2 in cancers and metabolic disorders;Frontiers in Oncology;2024-04-29

5. Cancer Vaccines in the Immunotherapy Era: Promise and Potential;Vaccines;2023-11-29